Marziyeh Anari 3rd Metabolic Diseases; Breakthrough Discoveries in Diabetes & Obesity 2022

Abstracts this author is presenting:

• Lipidomic profiling identifies hepatic phosphatidylserine synthesis as a novel signature of resistance to non-alcoholic steatohepatitis – Targeting of phosphatidylserine synthase 1 for therapeutic intervention — Poster Session 1